In addition, increased hepatic expression of Uncoupling protein 2 (UCP2), which is involved in the regulation of mitochondrial lipid efflux and oxidative metabolism [52], has been detected in NASH patients as compared to controls. This evidence concerns the gene UCP2 and metabolic dysfunction-associated steatohepatitis.